Cited by 59Pancreatic function and diabetesDiabetes Treatment and ManagementAdipokines, Inflammation, and Metabolic Diseases

β-cell adaptation in a mouse model of glucocorticoid-induced metabolic syndrome

Open access
Fransson, Liselotte, Franzén, Stephanie, Rosengren, Victoria, Wolbert, Petra, Sjöholm, Åke, Ortsäter, Henrik·2013·Journal of Endocrinology

Abstract

Glucocorticoids (GCs) are stress hormones primarily responsible for mobilizing glucose to the circulation. Due to this effect, insulin resistance and glucose intolerance are concerns in patients with endogenous overproduction of GCs and in patients prescribed GC-based therapy. In addition, hypercortisolemic conditions share many characteristics with the metabolic syndrome. This study reports on a thorough characterization, in terms of glucose control and lipid handling, of a mouse model where corticosterone is given via the drinking water. C57BL/6J mice were treated with corticosterone (100 or 25 μg/ml) or vehicle in their drinking water for 5 weeks after which they were subjected to insulin or glucose tolerance tests. GC-treated mice displayed increased food intake, body weight gain, and central fat deposit accumulations. In addition, the GC treatment led to dyslipidemia as well as accumulation of ectopic fat in the liver and skeletal muscle, having a substantial negative effect on insulin sensitivity. Also glucose intolerance and hypertension, both part of the metabolic syndrome, were evident in the GC-treated mice. However, the observed effects of corticosterone were reversed after drug removal. Furthermore, this study reveals insights into β-cell adaptation to the GC-induced insulin resistance. Increased pancreatic islet volume due to cell proliferation, increased insulin secretion capacity, and increased islet chaperone expression were found in GC-treated animals. This model mimics the human metabolic syndrome. It could be a valuable model for studying the complex mechanisms behind the development of the metabolic syndrome and type 2 diabetes, as well as the multifaceted relations between GC excess and disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/joe-13-0189

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Chronic administration of corticosterone in drinking water leads to hyperglycaemia, insulin resistance and dyslipidaemia in rodents.

    “Chronic administration of corticosterone in drinking water leads to hyperglycaemia, insulin resistance and dyslipidaemia in rodents 10, 11.”

    From Type 2 diabetes mellitus and psychological stress — a modifiable risk factor (2017) · cites this paper as [11]

    The dyslipidemia and glucose-control Results sections report dyslipidemia and insulin resistance in mice given corticosterone in drinking water. They report postprandial hyperglycaemia only at the higher dose; mice given the lower dose remained euglycaemic, and fasting glucose did not increase at either dose. The unqualified hyperglycaemia claim therefore overstates the finding. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fransson, L., Franzén, S., Rosengren, V., Wolbert, P., Sjöholm, Å., & Ortsäter, H.
Affiliations
  • Linköping University (SE)
  • University of South Alabama (US)
  • Karolinska Institutet (SE)
Venue
Journal of Endocrinology
Published
2013-09-17
Volume
219
Issue
3
Pages
231-241
ISSN
  • 0022-0795 (ISSN-L)
  • 1479-6805
OpenAlex
W2110172023
Cited by
59
References
55
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 8 · 2020: 5 · 2019: 8 · 2018: 6 · 2017: 5 · 2016: 8 · 2015: 1 · 2014: 3 · 2013: 1
FWCI
4.26
Type
journal article
Language
en
Open access
Locations
  • Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Tore Nilsons Stiftelse för Medicinsk Forskning
  • Diabetes Research and Wellness Foundation
  • Svenska Sällskapet för Medicinsk Forskning
  • Karolinska Institutet
  • Diabetesfonden
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
glucocorticoids, corticosterone, metabolic syndrome, beta-cell adaptation, insulin resistance, impaired glucose tolerance, hypercortisolism, dyslipidemia, ectopic fat deposition, insulin secretion, hypertension, type 2 diabetes, mouse model
MeSH terms
Administration, Oral, Animals, Behavior, Animal, Energy Intake, Disease Models, Animal, Glucocorticoids, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Stress, Physiological, Stress, Psychological, Weight Gain, Muscle, Skeletal, Metabolic Syndrome, Adiposity, Dyslipidemias, Insulin-Secreting Cells, Mice, Allostasis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review